1 | F | IPAH, 1 | 20 | 7/2/2007 | 32 | 14/7/2010 | 30 | 0.9 | 0.21 | 218 | 2360 | Ca2+ blocker |
2 | M | IPAH, 2 | 15 | 25/9/1995 | NA | 14/7/2010 | 37 | 7.05 | 0.7 | 376.3 | 1394.4 | Sildenafil+treprostinil (i.v.)+ambrisentan |
3 | F | IPAH, 2 | 9 | 29/6/2005 | 90 | 14/7/2010 | 28 | 4.23 | 0.55 | 201.5 | 2004 | Epoprostenol (i.v.)+ambrisentan |
4 | F | SPAH, 2 | 15 | 21/5/1999 | NA | 15/7/2010 | 54 | 3.8 | 0.42 | 242.6 | 1370.1 | Tadalafil+treprostinil (i.v.)+ambrisentan |
5 | M | SPAH, 4 | 19 | 21/03/2002 | 54 | 15/7/2010 | 55 | 7.49 | 0.75 | 271.7 | 1826.8 | Tadalafil+epoprostenol (i.v.)+ambrisentan |
6 | F | SPAH, 2 | 15 | 15/05/2002 | 71 | 21/7/2010 | 51 | 6.74 | 0.65 | 243 | 2022 | Tadalafil+treprostinil (inhaled) |
7 | F | IPAH, 2 | 10 | 7/10/2008 | 58 | 21/7/2010 | 35 | 4.54 | 0.56 | 396.2 | 1909.8 | Tadalafil+ambrisentan |
8 | M | SPAH, 3 | 17 | 6/10/1992 | NA | 11/8/2010 | 43 | 1.13 | 0.26 | 322.1 | 2260 | Tadalafil+treprostinil (inhaled) |
9 | F | SPAH, 1 | 12 | 21/11/1001 | 19 | 11/8/2010 | 23 | 6.3 | 0.43 | 353.4 | 2272 | Ca2+ blocker |
10 | F | SPAH, 1 | 9 | 1/2/2007 | 56 | 11/8/2010 | 18 | 1.3 | 0.19 | 202.5 | 1530.6 | Sildenafil+ambrisentan+Ca2+ blocker |
11 | M | IPAH, 2 | 2 | 20/08/2008 | NA | 11/8/2010 | 17 | 0.15 | 0.11 | 305.5 | 1175 | Sildenafil+treprostinil (i.v.) |
12 | M | IPAH, 1 | 15 | 1/8/2000 | NA | 11/8/2010 | 20 | 1.9 | 0.16 | 350 | 2764 | Tadalafil+iloprost+ambrisentan |
13 | F | SPAH, 2 | 12 | 19/5/2005 | NA | 11/8/2010 | 37 | 1.65 | 0.17 | 202.6 | 2408 | Sildenafil+bosentan |
14 | F | SPAH, 1 | 5 | 26/8/2009 | 38 | 25/8/2010 | 26 | 5.68 | 0.49 | 343.8 | 1732 | Ca2+ blocker |
15 | F | IPAH, 1 | 3 | 20/9/2007 | NA | 25/8/2010 | 24 | 3.8 | 0.36 | 376.9 | 1886.2 | Sildenafil |
16 | M | SPAH, 2 | 13 | 11/10/2001 | 73 | 25/8/2010 | 56 | 14.2 | 0.85 | 377.3 | 1963.2 | Sildenafil+treprostinil (i.v.)+ambrisentan |
17 | F | SPAH, 3 | 18 | 1/3/1996 | NA | 8/9/2010 | 61 | 7.66 | 0.72 | 330.3 | 2254 | Sildenafil+treprostini (i.v.)+bosentan |
18 | M | IPAH, 1 | 15 | 26/10/2005 | 70 | 8/9/2010 | 44 | 6.2 | 0.46 | 399.5 | 2414 | Tadalafil+ambrisentan |
19 | M | SPAH, 4 | 17 | 19/2/1997 | NA | 4/10/2010 | 80 | 4.5 | 0.39 | 343 | 2692 | Tadalafil+epoprostenol (i.v.)+bosentan |
20 | M | SPAH, 2 | 22 | 19/12/1995 | NA | 13/10/2010 | 32 | 4.5 | 0.46 | 240.2 | 1957.2 | Ambrisentan |
21 | M | IPAH, 2 | 10 | 17/12/2004 | 106 | 13/10/2010 | 74 | 6.5 | 0.66 | 327.1 | 1791.4 | Treprostinil (i.v.)+tadalafil |
22 | M | SPAH, 2 | 4 | 29/05/2007 | 20 | 13/10/2010 | 14 | 0.4 | 0.13 | 319.6 | 1904 | None |
23 | M | SPAH, 2 | 2 | 29/10/2009 | 28 | 21/10/2010 | 28 | 2.2 | 0.24 | 316.6 | 1495 | Sildenafil |
24 | M | SPAH, 1 | 1 | 22/12/2008 | NA | 10/11/2010 | 19 | 0.6 | 0.16 | 212 | 1429.8 | Sildenafil |
25 | M | SPAH, 1 | 3 | 8/3/2010 | NA | 10/11/2010 | 32 | 3 | 0.37 | 382.4 | 1933.6 | Sildenafil |
26 | F | IPAH, 1 | 11 | 10/10/2005 | 48 | 10/11/2010 | 41 | 4 | 0.46 | 293.2 | 1785.4 | Tadalafil+bosentan |